Photo of John H. Rutherford
R United States House · District 5 · Florida On the 2026 ballot

Rep. John H. Rutherford

Compare
Total votes
2,837
all sessions
Attendance
96%
125 missed
Lower than 91% of chamber peers
With party
94%
of cast votes
Higher than 87% of chamber peers
Bipartisan score
3%
crosses aisle rarely
Lower than 88% of chamber peers
Sponsored
1,242
bills & resolutions
Near the chamber average
Committees
4
assignments
1,242 bills and resolutions

Sponsored bills

Total
1,242
Primary
29
Co-sponsor
1,213
This page
1,242
matching current filters
Co-sponsor HR 6471
In committee · United States House · Co-sponsor
Protecting Life in Health Savings Accounts Act

Protecting Life in Health Savings Accounts Act This bill prohibits distributions from health savings accounts (HSAs) or other tax-preferred savings accounts for abortions except for abortions to terminate a pregnancy that is the result or rape or incest or to protect a women's health or life.

In committee Jan 21, 2022 1 co-sponsor
Co-sponsor HR 6413
In committee · United States House · Co-sponsor
Keep Kids in Schools Act

Keep Kids in Schools Act This bill prohibits a local educational agency (LEA) from obligating federal COVID-19 relief funds during any period when one or more elementary or secondary schools served by the LEA do not provide full-time, in-person instruction. This prohibition does not apply with respect to a school that does not provide full-time, in-person instruction due to following quarantine or isolation guidelines issued by the Centers for Disease Control and Prevention.

In committee Jan 18, 2022 1 co-sponsor
Co-sponsor HR 3537
Signed into law · United States House · Co-sponsor
Accelerating Access to Critical Therapies for ALS Act

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials.  The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.

Signed into law Dec 23, 2021 1 co-sponsor
Co-sponsor HR 6308
In committee · United States House · Co-sponsor
ACO Assignment Improvement Act of 2021

ACO Assignment Improvement Act of 2021 This bill establishes additional requirements for assigning Medicare fee-for-service beneficiaries to accountable care organizations (ACOs) under the Medicare shared savings program. Under current law, the program enables ACOs to receive payments for savings stemming from care coordination and management. The bill requires the basis for assignment to reflect beneficiaries' utilization of not only primary care services provided by ACO physicians, but also those provided by other ACO practitioners—specifically, physician assistants, nurse practitioners, and clinical nurse specialists.

In committee Dec 17, 2021 1 co-sponsor
Co-sponsor HR 6299
In committee · United States House · Co-sponsor
Protecting Our Democracy by Preventing Foreign Citizens from Voting Act

Protecting Our Democracy by Preventing Foreign Citizens from Voting Act This bill prohibits federal funds from being made available to state or local governments that allow noncitizens to vote in federal, state, or local elections.

In committee Dec 16, 2021 1 co-sponsor
Co-sponsor HR 5142
Signed into law · United States House · Co-sponsor
To award posthumously a Congressional Gold Medal, in commemoration to the servicemembers who perished in Afghanistan on August 26, 2021, during the evacuation of citizens of the United States and Afghan allies at Hamid Karzai International Airport, and for other purposes.

This bill posthumously provides for the award of a Congressional Gold Medal in commemoration of the 13 service members who died on August 26, 2021, while stationed at Hamid Karzai International Airport in Afghanistan.

Signed into law Dec 16, 2021 1 co-sponsor
Co-sponsor HR 6202
In committee · United States House · Co-sponsor
Telehealth Extension Act of 2021

Telehealth Extension Act of 2021 This bill expands and otherwise modifies coverage of telehealth services under Medicare. Specifically, the bill permanently (1) removes geographic restrictions on originating sites (i.e., the location of the beneficiary), (2) allows the home of the beneficiary to serve as the originating site for all services, and (3) allows federally qualified health centers and rural health clinics to serve as the distant site (i.e., the location of the health care practitioner). The bill also extends any Medicare telehealth flexibilities that were granted during the COVID-19 public health emergency until two years after the emergency ends and generally allows such flexibilities to be granted during any public health emergency. In addition, the bill (1) allows for Medicare payment of outpatient critical access hospital services consisting of telehealth behavioral therapy until two years after the COVID-19 public health emergency ends; and (2) after the emergency ends, conditions payment for certain high-cost laboratory tests and durable medical equipment that are ordered via telehealth on at least one in-person visit during the preceding six-month period.

In committee Dec 10, 2021 1 co-sponsor
Co-sponsor HR 6145
In committee · United States House · Co-sponsor
Community Bank Relief Act of 2021

Community Bank Relief Act of 2021 This bill requires banking agencies to set the community bank leverage ratio between 8% and 8.5% for calendar years 2022, 2023, and 2024 for community banks seeking to satisfy simplified capital adequacy requirements. Currently, banking agencies are statutorily required to set the rate between 8% and 10% through rulemaking. Under current regulations, the rate will increase from 8.5% to 9% on January 1, 2022.

In committee Dec 7, 2021 1 co-sponsor
Co-sponsor HR 6161
In committee · United States House · Co-sponsor
Employee Retention Tax Credit Reinstatement Act

Employee Retention Tax Credit Reinstatement Act This bill provides for a reinstatement of the employee retention tax credit through 2021. The credit was established to compensate employers whose businesses were negatively impacted by the COVID-19 pandemic for wages paid to their employees.

In committee Dec 7, 2021 1 co-sponsor
Co-sponsor HR 6171
In committee · United States House · Co-sponsor
CNL Update Act

CNL Update Act This bill makes changes to the procedures for competitive need limitations (CNL) and de minimis waivers under the Generalized System of Preferences (GSP) program. CNLs are quantitative ceilings on GSP benefits for each product and beneficiary developing country; a beneficiary developing country loses its GSP eligibility with respect to a product if the CNLs are exceeded and no waiver is granted. Currently, the President must terminate the duty-free treatment for a product from a beneficiary developing country if (1) imports of a product from a single country reach a specified threshold value, which increases by $5 million each calendar year; or (2) 50% or more of total U.S. imports of a product entering under the GSP come from a single country. This bill revises the annual adjustment amount from $5 million to an amount equal to 6.5%. Further, the bill sets the annual increase in the de minimis level to 6.5%. Currently, the de minimis level is adjusted each year in increments of $500,000.

In committee Dec 7, 2021 1 co-sponsor
Showing 951 to 960 of 1,242 bills
Previous 1 … 95 96 97 … 125 Next